Device in the form of a bandage patch with ingredients for bug bite relief
US-2024335326-A1 · Oct 10, 2024 · US
US10772767B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10772767-B2 |
| Application number | US-201414899608-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 12, 2014 |
| Priority date | Jun 28, 2013 |
| Publication date | Sep 15, 2020 |
| Grant date | Sep 15, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A fibrin-coated wound dressing article having a flexible film layer, a pressure-sensitive adhesive layer disposed on the flexible film layer, and a fibrin powder layer disposed on a surface of the pressure-sensitive adhesive layer opposite the flexible film layer. Methods of making and using fibrin-coated wound dressing articles are included.
Opening claim text (preview).
What is claimed is: 1. A wound dressing article comprising: a flexible film layer; a pressure-sensitive adhesive layer disposed on the flexible film layer; an absorbent layer disposed between the flexible film layer and the pressure-sensitive adhesive layer; and a fibrin powder layer disposed on a surface of the pressure-sensitive adhesive layer opposite the flexible film layer; the pressure sensitive adhesive layer extends into and through a portion of absorbent layer. 2. The article of claim 1 , wherein the fibrin powder comprises fibrin powder particles in the form of microspheres, amorphous particles, or a mixture thereof. 3. The article of claim 2 , wherein the fibrin powder particles have an average particle size in largest dimension of up to 100 micrometers. 4. The article of claim 1 , wherein a coating weight of the fibrin powder layer is in a range from 0.2 to 20 milligrams per cm 2 . 5. The article of claim 1 , wherein the fibrin powder layer contains fibrin in a range of 1 to 99 percent by weight, relative to a total weight of the fibrin powder layer. 6. The article of claim 1 , wherein the surface of the flexible film layer having the pressure-sensitive adhesive layer disposed thereon comprises a microstructured surface. 7. The article of claim 1 , wherein the pressure-sensitive adhesive layer is discontinuous. 8. The article of claim 1 , wherein the absorbent layer comprises a nonwoven or a fiber material. 9. The article of claim 8 , wherein the fiber material comprises sheath-core fiber having a central core of absorbent fiber and a sheath comprising pressure-sensitive adhesive. 10. The article of claim 1 , further comprising a release liner, wherein the fibrin powder layer is disposed between the pressure-sensitive adhesive layer and the release liner. 11. The article of claim 1 , wherein the flexible film layer is substantially transparent. 12. The article of claim 1 , wherein the fibrin powder layer comprise at least one additive. 13. An article comprising the wound dressing article of claim 1 positioned in a sealed packaged. 14. The article of claim 13 , wherein the sealed package comprises a sterile interior. 15. A method of making a wound dressing article, the method comprising: providing a flexible film layer; disposing a pressure-sensitive adhesive layer on the flexible film layer; disposing an absorbent layer between the flexible film layer and the pressure-sensitive adhesive layer; forming a fibrin powder layer on a surface of the pressure-sensitive adhesive layer opposite the flexible film layer to prepare the wound dressing article; wherein the absorbent layer is an open cell foam having open cells; wherein the pressure sensitive adhesive layer extends into and through a portion of the absorbent layer. 16. The method of claim 15 , wherein forming the fibrin powder comprises drying a fibrin-containing gel to form a dried fibrin-containing composition, and crushing the dried fibrin-containing composition to form the fibrin powder. 17. The method of claim 14 , further comprising subjecting the wound dressing article to terminal sterilization, wherein the terminal sterilization comprises gamma irradiation. 18. A method of treating a wound, comprising applying a wound dressing article according to claim 1 to an external wound on a mammal. 19. The method of claim 18 , wherein the mammal is a human. 20. The article of claim 1 , wherein the absorbent layer is an open cell foam. 21. A wound dressing article comprising: a flexible film layer; a pressure-sensitive adhesive layer disposed on the flexible film layer; an absorbent layer disposed between the flexible film layer and the pressure-sensitive adhesive layer; and a fibrin powder layer disposed on a surface of the pressure-sensitive adhesive layer opposite the flexible film layer; wherein the absorbent layer is an open cell foam having open cells; wherein portions of the pressure-sensitive adhesive layer extends over the open cells.
Medicaments · CPC title
Tissue-regenerating or healing or proliferative agents · CPC title
Porous materials, e.g. foams or sponges · CPC title
manufacturing of adhesive dressings · CPC title
Methods for coating medical devices · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.